233 related articles for article (PubMed ID: 30014527)
1. BRAF mutation leading to central nervous system rosai-dorfman disease.
Richardson TE; Wachsmann M; Oliver D; Abedin Z; Ye D; Burns DK; Raisanen JM; Greenberg BM; Hatanpaa KJ
Ann Neurol; 2018 Jul; 84(1):147-152. PubMed ID: 30014527
[TBL] [Abstract][Full Text] [Related]
2. How I Diagnose Rosai-Dorfman Disease.
Ravindran A; Rech KL
Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
[TBL] [Abstract][Full Text] [Related]
3. [Cutaneous Rosai-Dorfman disease with lack of BRAF-V600, KRAS or NRAS mutations: A reactive or neoplastic disorder?].
Machado I; Alcacer Fernández-Coronado J; Requena C; Través V; Latorre Martínez N; Ortega J; Requena L; Alcacer García J
Rev Esp Patol; 2022; 55(1):52-56. PubMed ID: 34980442
[TBL] [Abstract][Full Text] [Related]
4. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
[TBL] [Abstract][Full Text] [Related]
5. Rosai-Dorfman disease in the central nervous system with two isolated lesions originated from a single clone: a case report.
Jin H; Yu Z; Tian T; Shen G; Chen W; Fan M; He Q; Xu F; Liu D
BMC Neurol; 2021 Sep; 21(1):352. PubMed ID: 34517832
[TBL] [Abstract][Full Text] [Related]
6. Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.
Shanmugam V; Margolskee E; Kluk M; Giorgadze T; Orazi A
Head Neck Pathol; 2016 Sep; 10(3):394-9. PubMed ID: 26922062
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic analysis of extranodal Rosai-Dorfman disease of breast: a report of 12 cases].
Chen YP; Jiang XN; Lu JP; Zhang H; Li XQ; Chen G
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):556-60. PubMed ID: 27510782
[TBL] [Abstract][Full Text] [Related]
8. [Rosai-Dorfman disease: clinicopathologic, immunohistochemical and etiologic study of 16 cases].
Yu JB; Liu WP; Zuo Z; Tang Y; Liao DY; Ji H; Bai YQ; Li SH; Lu CQ; Luo HB
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):33-8. PubMed ID: 17374236
[TBL] [Abstract][Full Text] [Related]
9. Rosai-Dorfman disease of the central nervous system.
Purav P; Ganapathy K; Mallikarjuna VS; Annapurneswari S; Kalyanaraman S; Reginald J; Natarajan P; Bapu KR; Balamurugan M
J Clin Neurosci; 2005 Aug; 12(6):656-9. PubMed ID: 16099162
[TBL] [Abstract][Full Text] [Related]
10. Recurrent central nervous system Rosai-Dorfman disease with KRAS mutation: a case report.
Wang Q; Ren H; Zheng L; Wang J; Zhong D
Diagn Pathol; 2023 Feb; 18(1):21. PubMed ID: 36782249
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients.
Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F
Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919
[TBL] [Abstract][Full Text] [Related]
12. A lethal intracranial Rosai-Dorfman disease of the brainstem diagnosed at autopsy.
Imada H; Sakatani T; Sawada M; Matsuura T; Fukushima N; Nakano I
Pathol Int; 2015 Oct; 65(10):549-53. PubMed ID: 26184902
[TBL] [Abstract][Full Text] [Related]
13. [Primary intraosseous Rosai-Dorfman disease: a clinicopathological analysis of fourteen cases].
Dong RF; Gong LH; Zhang W; Li L; Sun XQ; Zhang M; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):904-909. PubMed ID: 32892555
[No Abstract] [Full Text] [Related]
14. Fine-needle aspiration specimens of 3 cases of intra-abdominal Rosai-Dorfman disease with comprehensive review of the literature.
McIntire PJ; Kilic AI; Chen HH; Atieh M; Wojcik EM; Pambuccian SE
J Am Soc Cytopathol; 2019; 8(4):190-205. PubMed ID: 31272602
[TBL] [Abstract][Full Text] [Related]
15. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
[TBL] [Abstract][Full Text] [Related]
16. KRAS 117N positive Rosai-Dorfman disease with atypical features.
Jafri ZA; Reddy SP; Cassarino DS
J Cutan Pathol; 2021 Jan; 48(1):147-150. PubMed ID: 32974961
[TBL] [Abstract][Full Text] [Related]
17. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
Haroche J; Abla O
Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous adult xanthogranuloma with a small portion of BRAF
Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
[TBL] [Abstract][Full Text] [Related]
19. Rosai-Dorfman disease isolated to the central nervous system: a report of 11 cases.
Andriko JA; Morrison A; Colegial CH; Davis BJ; Jones RV
Mod Pathol; 2001 Mar; 14(3):172-8. PubMed ID: 11266522
[TBL] [Abstract][Full Text] [Related]
20. Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis.
Janku F; Diamond EL; Goodman AM; Raghavan VK; Barnes TG; Kato S; Abdel-Wahab O; Durham BH; Meric-Bernstam F; Kurzrock R
Mol Cancer Ther; 2019 Jun; 18(6):1149-1157. PubMed ID: 31015311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]